Expanding of INNventa otorhinolaryngology portfolio-Laringinn® and Rhinosinn®

In addition to Serapinn product that has been successfully prescribed and used for a year and a half in the treatment of inflammation processes, and Serapinn forte launched in December 2017, Innventa has expanded its Otorhinolaryngology portfolio with two new products Laringinn and Rhinosinn. These two products are sprays for nose and throat used in [...]